The role of intensive remission induction and consolidation therapy in patients with acute myeloid leukaemia.

@article{Tricot1987TheRO,
  title={The role of intensive remission induction and consolidation therapy in patients with acute myeloid leukaemia.},
  author={Guido Tricot and Marc A. Boogaerts and Robert F M H Vlietinck and Marie Paule Emonds and R. L. Verwilghen},
  journal={British journal of haematology},
  year={1987},
  volume={66 1},
  pages={37-44}
}
Sixty-one patients with AML, 59 adults and two children, were treated with intensive remission induction and consolidation therapy. The median age was 36 years. Forty-four (72%) patients entered complete remission (CR); 11 patients received a bone marrow transplantation. The median survival of complete remitters was 26.5 months; the probability of remaining in CR at respectively 1 and 2 years was 75% and 62%. The only factor significantly correlated with the outcome of remission induction… CONTINUE READING